is a human poxvirus that causes abnormal proliferation of epithelial cells. MCV encodes specific molecules to control host defences, such as MC159L, which as previously shown prevents apoptosis induced by death receptors. However, unlike most poxviruses, MCV lacks a homologue to the E3L and K3L proteins of vaccinia virus, which are involved in the control of the key antiviral and pro-apoptotic dsRNA-dependent protein kinase, PKR. In this study, we analysed the relationship of MC159L to PKR. We found that MC159L is not a direct inhibitor of PKR since it does not associate with PKR and cannot block PKR-induced phosphorylation of eIF-2α. However, expression of MC159L inhibits apoptosis triggered by PKR through death receptor-mediated pathways. In addition, MC159L inhibits NF-κB activation induced in response to PKR. Expression of MC159L cannot counteract the PKR-mediated antiviral action in the context of a poxvirus infection, despite its ability to affect these signalling events. These findings show that MC159L is able to interfere with downstream events triggered by PKR in the absence of a direct physical interaction, and assign a role to MC159L in the control of some PKR-mediated biological effects.
Introduction
The control of host antiviral strategies is a key point for efficient virus replication. To this end, viruses have to modulate many different cellular pathways, such as those involved in apoptosis induction, cytokine production and several dsRNAactivated antiviral pathways (Jacobs & Langland, 1996) . A central enzyme involved in antiviral activity is the dsRNAdependent protein kinase, PKR. This serine\threonine kinase is composed of 551 amino acid residues in humans (Meurs et al., 1990 ;  for review see Clemens & Elia, 1997) and is activated upon dsRNA binding and subsequent autophosphorylation. PKR controls diverse cellular processes such as cell growth (Chong et al., 1992) , differentiation (Petryshyn et al., 1984) and apoptosis (Lee & Esteban, 1994) , and also exerts antitumour (Koromilas et al., 1992 ; Meurs et al., 1993) and antiviral activities (Lee et al., 1996 ; Lee & Esteban, 1993) . In fact, PKR has been shown to control the replication of vesicular stomatitis virus, vaccinia virus (VV) and many other viruses (Lee et al., 1996 ; Lee & Esteban, 1993 ; for a review see . The key role of PKR in controlling virus infections is underscored by the fact that viruses have developed multiple strategies to avoid PKR deleterious effects at different levels , such as inhibition of PKR activation (VAI RNAs from adenovirus ; Katze et al., 1987) , sequestration of dsRNA (NS1 of influenza virus, sigma 3 of reovirus ; Lloyd & Shatkin, 1993 ; Lu et al., 1995) , inhibition of PKR dimerization [NS5A protein of hepatitis C virus (HCV) ; Gale et al., 1997 ], synthesis of PKR pseudosubstrates (E2 protein of HCV or baculovirus PK2 ; Taylor et al., 1999 ; , activation of antagonist phosphatases (γ " 34.5 from herpesvirus ; He et al., 1997) or PKR degradation (induced by poliovirus ; Black et al., 1989) . Poxviruses are not an exception and have also developed multiple strategies to counteract IFN and particularly PKR action (Smith et al., 1998) . In addition to secreted receptors to block IFN action, VV encodes at least two proteins with the capacity to inhibit IFN-induced pathways, like the PKR pseudosubstrate K3L and the dsRNAbinding protein E3L (Davies et al., 1993) . The latter interferes not only with PKR but also with different dsRNA-dependent pathways (Rivas et al., 1998 ; Smith et al., 1998) . Sequence data from different poxviruses such as variola, myxoma, yaba-like disease viruses and orf also identified E3L-and\or K3L-related genes (McInnes et al., 1998 ; Shchelkunov et al., 1993) .
Molluscum contagiosum virus (MCV) is a member of the poxvirus family, provoking benign skin tumours in humans (Buller, 1999) . Despite extensive homologies, with regard to structural proteins, with the most characterized member of the poxvirus family, VV, factors involved in modulation of host responses to infection are not conserved between MCV and VV (Senkevich et al., 1996 . In particular, the sequence of MCV contains neither an E3L nor a K3L homologue. In contrast, MCV encodes a set of regulators of host response (for a review see Moss et al., 2000) , such as a glutathione peroxidase, involved in prevention of ultraviolet-induced cell death (MC066L ; Shisler et al., 1998) , a protein involved in inhibiting chemokine action (MC148R ; Krathwohl et al., 1997 ; Damon et al., 1998) , another protein that modulates the action of steroid receptors (Chen et al., 2000) and at least three genes belonging to a family of IL-18 binding proteins . In addition, MCV encodes two proteins, MC159L and MC160L, containing death effector domains (DEDs), which belong to a family of cellular and viral FLIP (vFLIP)-like proteins (Bertin et al., 1997 ; Hu et al., 1997 ; Thome et al., 1997) . Although proteins MC159L and MC160L have a similar structure, only MC159L has been shown to inhibit apoptosis induced in response to death receptor FADD (Bertin et al., 1997 ; Hu et al., 1997 ; Thome et al., 1997) . MC159L physically interacts with FADD (Bertin et al., 1997 ; Hu et al., 1997 ; Thome et al., 1997) , thus explaining its physiological function. In addition, recent work (Chaudhary et al., 1999) has suggested that this FLIP-like viral protein also inhibits NF-κB induction, triggered by activation of caspase 8 and its homologues. Since PKR is able to induce NF-κB activation and to trigger a translational block through phosphorylation of the small subunit of the initiation factor eIF-2 (eIF-2α), in this investigation we have examined the ability of MC159L to modulate PKR-induced pathways. We have evaluated whether MC159L directly interacts with PKR acting as a general inhibitor of PKR or whether its action is limited to a more specific interference with PKR-triggered pathways downstream of PKR activation.
Methods
Materials. Monoclonal antibody recognizing total eIF-2α was a gift from Ce! sar de Haro (CBMSO-UAM, Madrid, Spain). Polyclonal antibodies directed against phosphorylated eIF-2α were from Biosource. Antibodies recognizing PKR have been described previously (Gil et al., 1999) . Antibodies against the Xpress epitope were from Novagen.
Plasmids. The DNA from the MC159L protein of MCV was amplified by PCR from DNA obtained from a patient with MCV lesions, and cloned in the VV insertional vector pHLZ as previously described .
Cells and viruses. African green monkey kidney cells BSC-40 (ATCC CCL-26) were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10 % heat-inactivated newborn calf serum (NCS). HeLa cells (ECACC 85060701) were grown in DMEM supplemented with 10 % NCS. After mock inoculation or virus adsorption, cells were maintained in DMEM supplemented with 2 % NCS or 2 % FCS.
The recombinant VV (rVV) expressing IPTG-inducible PKR (VV PKR) has been previously described (Lee & Esteban, 1993) . VV MC159L, a rVV constitutively expressing an Xpress epitope N-terminal-tagged MC159L coding fragment, and VV PKR-MC159L, which expresses IPTG-inducible PKR and MC159L constitutively, have been described before .
Gel retardation assay. Nuclear extracts were prepared as previously described (Arenzana-Seisdedos et al., 1995) . Three µg of nuclear extracts was analysed using [α-$#P]dCTP-labelled doublestranded synthetic wild-type human immunodeficiency virus enhancer oligonucleotide 5h AGC TTA CAA GGG ACT TTC CGC TGG GGA CTT TCC AGG GA 3h containing the two κB consensus motifs.
Measurement of the extent of apoptosis. The cell death detection ELISA kit (Roche) was used according to the manufacturer's instructions. This assay is based on the quantitative enzyme sandwich immunoassay principle and uses mouse monoclonal antibodies directed against DNA and histones to estimate the amount of cytoplasmic histone-associated DNA.
Caspase 3 activity assay. 3i10' cells were collected in lysis buffer (150 mM KCl, 10 % glycerol, 1 mM dithiothreitol, 5 mM magnesium acetate, 0n5 % Nonidet P-40) and clarified by centrifugation. Equal amounts of supernatant and 2i reaction buffer (100 mM HEPES pH 7n5, 20 % glycerol, 5 mM dithiothreitol, 0n5 mM EDTA) were mixed and assayed for caspase 3 activity using as substrate 200 µM DEVD-pNA from Calbiochem. Free pNA produced by caspase activity was determined by measuring absorbance at 405 nm.
In vitro analyses of PKR-MC159L interaction. PKR! /! cells infected for 20 h with VV PKR or with control VV were immunoprecipitated using a PKR antiserum. Washed immunocomplexes were then incubated for 1 h at 25 mC with $&S-labelled proteins obtained from in vitro transcription\translations of plasmids carrying MC159L and E3L cDNAs under the transcriptional control of a T7 promoter using the TNT T7 Quickcoupled system (Promega). Upon incubation, resins were extensively washed and bound proteins analysed by SDS-PAGE followed by autoradiography.
Measurement of β-galactosidase activity.
Confluent BSC-40 cells seeded in 24-well plates were infected with 5 p.f.u. per cell of the indicated viruses. After 1 h of virus adsorption 5 mM IPTG was added to induce PKR expression. Cells were collected at indicated times, resuspended in 100 µl of 0n25 M Tris, pH 7n8, and lysed by three freeze-thaw cycles. Lysis extracts were diluted to 1 ml with water, centrifuged and 10 µl of supernatant was used for β-galactosidase determination. Cell lysate supernatants (10 µl) were mixed with 150 µl of CPRG solution (1 mM MgCl # , 45 mM β-mercaptoethanol, 0n1 M sodium phosphate, pH 7n5, 5 mM CPRG) in a 96-well plate, incubated at 37 mC for 1 h and absorbance at 540 nm was determined.
Immunoblotting. For immunoblot analysis, total cell extracts were fractionated by SDS-PAGE and proteins were transferred to nitrocellulose paper. Filters were incubated with antiserum overnight at 4 mC, then incubated with secondary antibody and reactivity was detected using ECL Western blotting reagents (Amersham). Exposure of filters to Kodak X-OMAT films was performed for the necessary time. 2) , VV MC159L (lanes 3, 4) and VV PKR (lanes 5, 6) (A) or VV (lanes 1, 2), VV PKR (lanes 3, 4) and VV PKR-MC159L (lanes 5, 6) (B). Expression of PKR proteins was induced by adding 5 mM IPTG at 1 h p.i., and cells were collected at the times indicated (16 or 20 h p.i.), nuclear extracts were prepared as described in Methods and used to perform a NF-κB EMSA. Positions of the NF-κB shifted complexes were defined by competition and supershift experiments and are indicated with an arrow.
Results

MC159L inhibits PKR-induced apoptosis
The MC159L open reading frame encodes a vFLIP homologue which interferes with the apoptosis pathway triggered by certain death receptors through sequestration of FADD . In order to study the relationship of MC159L to PKR, we used two VV recombinants encoding either MC159L alone or MC159L together with PKR. A scheme of vectors with the inserted cassette in two loci of the VV genome is shown in Fig. 1 (A) . To easily monitor expression of the MC159L protein, a tag was added in its N-terminal extreme as an Xpress epitope. A Western blot showing correct expression of PKR and MC159L from the different VV recombinants is shown in Fig. 1 (B) . To test the ability of the MC159L protein to inhibit PKR-induced apoptosis, HeLa cells were infected with a rVV expressing either PKR alone or coexpressing PKR together with the MC159L protein. Coexpression of MC159L together with PKR abrogated the capacity of PKR to induce apoptosis, as measured both by a HeLa cells were infected with the indicated viruses (5 p.f.u. per cell) and PKR expression was induced or not by adding the indicated concentrations of IPTG after virus adsorption for 1 h. Cells were collected at the times indicated and subjected to immunoblot analysis using anti-eIF-2α-specific monoclonal antibodies and a polyclonal antiserum that specifically recognizes the phosphorylated form of eIF-2α. (B) Monolayers of BSC-40 cells were infected with VV PKR or VV PKR-MC159L viruses (5 p.f.u. per cell) and after 1 h of virus adsorption, inoculum was removed and new media with or without 5 mM IPTG was added. At selected times cells were harvested and extracts prepared for β-galactosidase activity measurement. caspase 3 assay and by oligonucleosomal cytoplasmic complexes ( Fig. 1 C ; . These results show that MC159L is able to interfere with apoptotic effects triggered by PKR activation, and provide support to further analyse the ability of MC159L to modulate PKR signalling.
MC159L inhibits NF-κB activation triggered by PKR
Different proteins containing DEDs have been shown to activate or to inhibit NF-κB activation in certain conditions (Chaudhary et al., 1999) . Since PKR is able to induce NF-κB through IKK activation (Kumar et al., 1994 ; , the effect of MC159L over PKR-induced NF-κB activity was analysed. As shown in Fig. 2 (A) , PKR expression induced NF-κB activity, as measured by gel shift assay. However, expression of MC159L was unable to induce NF-κB activation on its own, as described before (Chaudhary et al., 1999 ; Fig. 2 A) and differing from what has been reported for other proteins of the FLIP family (Chaudhary et al., 1999 ; Kataoka et al., 2000) . When MC159L and PKR were co-expressed, MC159L reduced the NF-κB binding induced upon PKR expression by more than 50 % between 16-20 h p.i. in a reproducible manner (n l 3 ; Fig. 2 B) . These findings highlight the ability of MC159L to inhibit PKR-induced processes such as apoptosis and NF-κB activation.
MC159L does not affect translational control induced by PKR
One of the major biological functions of PKR is to control translation through phosphorylation of eIF-2α. Since MC159L appears to affect several PKR-induced actions, next we determined the effect of MC159L over eIF-2α phosphorylation induced by PKR. Thus, HeLa cells were infected with either a rVV expressing PKR alone or co-expressing PKR in conjunction with MC159L, and the levels of eIF-2α phosphorylation were measured in cell extracts by Western blot with antibodies that recognize total eIF-2α and the phosphorylated form of the protein. As shown in Fig. 3 (A) , MC159L does not affect PKR-induced eIF-2α phosphorylation (compare upper and lower panels). As the recombinant viruses used contain the lacZ gene in the viral genome (Fig. 1) , to quantify the effect of MC159L on the extent of inhibition of protein synthesis by PKR, β-gal activity was measured in extracts from cells infected with rVV expressing PKR or co-expressing both PKR and MC159L. As shown in Fig. 3 (B) , MC159L had no effect over the inhibitory action of PKR on β-gal activity levels.
To further study the relationship between PKR and MC159L, in vitro binding assays were performed. PKR! /! cells were infected with VV PKR or VV for 20 h followed by incubation of cell extracts with anti-PKR serum coupled to protein A-Sepharose. The immunocomplexes were then incubated with [$&S]methionine\cysteine-labelled MC159L protein obtained by in vitro transcription and translation ; as positive control we used E3L protein of VV that has been shown to physically interact with PKR (Romano et al., 1998) . Following thorough washings, bound proteins were analysed by SDS-PAGE and autoradiography. As shown in Fig. 4, E3L protein was detectable in PKR immunocomplexes from VV PKR and from VV-infected cells, in a manner reflecting PKR levels (background levels observed in VV-infected cells are due to residual PKR from reticulocyte lysates). However MC159L was unable to bind to PKR immunocomplexes to a significant extent, (lanes 2 and 4) . The above findings suggest that there is no physical interaction between MC159L and PKR.
MC159L does not overcome antiviral effects of PKR
A major biological role of PKR is the control of virus infections , a process mediated mainly by inhibition of translation of viral proteins (Balachandran et al., 2000) . To evaluate if MC159L can overcome the antiviral activity of PKR in the context of a virus infection, we took advantage of the VV PKR system, in which expression of PKR is regulated by IPTG addition and this expression correlates with inhibition of VV replication (Lee & Esteban, 1993) . Two different approaches were used to measure virus replication, one based on virus plaque formation and the other based on measuring virus yields with time post-infection. As observed in Fig. 5 , cells infected with VV PKR in the presence of IPTG developed an antiviral state (both plaques and virus yields were severely restricted) compared to control VV and to another rVV expressing IRF2 in an IPTG-inducible way. However, co-expression of PKR and MC159L had little effect on the antiviral action of PKR. When the same experiment was performed infecting cells with a rVV co-expressing PKR and p67, a PKR inhibitor (Gil et al., 2000 b) , we observed a reversal of the antiviral action of PKR. These experiments suggest that MC159L expression is not enough to overcome PKR antiviral action in the context of a poxvirus infection.
Discussion
A common mechanism for the control of virus infection involves activation of the protein kinase PKR by dsRNA accumulated as a by-product of virus replication. Moreover, the importance of PKR as an antiviral strategy is highlighted by the different mechanisms used by viruses to counteract its action. The prototypic poxvirus, VV, encodes K3L and E3L, two PKR inhibitors. Homologues to both of these proteins have been found in genomes of many other poxviruses, but not in the MCV genome. The strategies that MCV uses to control host defences are beginning to be understood (Moss et al., 2000) , but how MCV controls PKR action remains unknown.
Since MCV cannot be grown in vitro and consequently cannot be genetically modified, it becomes difficult to study the function of genes involved in the virus life-cycle, replication and interaction with the host. The use of rVV is an effective approach to this problem. To investigate the relationship of MC159L with PKR, we used VV recombinants that singly express PKR or MC159L and doubly express PKR and MC159L. Expression of PKR was under an IPTG-inducible promoter, while MC159L was expressed constitutively. Through various assays measuring apoptosis, NF-κB activation, protein-protein interaction and antiviral effects, we present evidence suggesting that the MC159L protein interferes with PKR action.
We found that the MC159L protein from MCV regulates PKR action at two different levels, inhibiting apoptosis and blocking NF-κB activation (Figs 1 C and 2) . The effect of MC159L on PKR-induced apoptosis is especially interesting because MCV infection persists for months and sometimes for years in patients. Therefore, inhibition of PKR-induced cell death could be a key mechanism for virus persistence (Kaufman, 1999 ; Yeung et al., 1999) . Disruption of death receptorinduced apoptosis by MC159L and other vFLIP-like proteins has been associated with their ability to interact with FADD, thus blocking caspase 8 activation. Since PKR induces apoptosis through FADD-mediated activation of caspase 8 , this pathway probably represents the mechanism of inhibition of PKR-triggered cell death by MC159L.
We have also found that MC159L is able to inhibit NF-κB activation induced by PKR. Although FLIP, the cellular homologue of MC159, is not required for NF-κB activation in response to TNF-α treatment, as shown in knockout studies (Yeh et al., 2000) , when it is overexpressed it is able to activate NF-κB and Erk pathways through recruitment of adapter molecules (Kataoka et al., 2000) . In a similar fashion, some vFLIP proteins have been shown to induce NF-κB (Chaudhary et al., 1999) . Our data show that MC159L has the ability to counteract NF-κB activation triggered by PKR. Other investigators had attributed to MC159L a role in the inhibition of NF-κB in response to caspase 8 activation (Chaudhary et al., 1999) , but this is the first evidence showing that MC159L interferes with activation of NF-κB in response to PKR.
A major role has been attributed to eIF-2α phosphorylation in mediating PKR-induced effects, but there is increasing evidence which assigns to PKR a more important role in the regulation of different transcriptional pathways, in particular the one involving NF-κB. Thus, NF-κB activation triggered by PKR is involved in apoptosis induction (Gil et al., 1999) and in imposing an antiviral state through the production of IFN and other pro-inflammatory cytokines (Chu et al., 1999) . Moreover, since NF-κB has been allocated as a key regulator of the transcription of multiple genes involved in inflammation, we should not underestimate the regulatory effects exerted by MC159L over the PKR-triggered NF-κB pathway as an anti-inflammatory mechanism. Interestingly, the ability of MC159L to inhibit NF-κB activation has been associated to sequestration of IKK activators, such as RIP or TRAFs (Chaudhary et al., 1999) . Thus, it seems possible that PKR could activate IKK through some common molecule upstream of the IKK complex, thus explaining why MC159L inhibits the process. The explanation of this observation will emerge from a better knowledge of the transduction pathways triggered by PKR.
Herpesviruses encode for a protein that, although is not a direct PKR inhibitor, targets the eIF-2α phosphorylation pathway through recruitment and activation of a phosphatase with the ability to revert the translational block imposed by PKR (He et al., 1997) . Thus, the effect of MC159L on PKR could be explained in a similar fashion, not by directly inhibiting PKR but by blocking several PKR-dependent pathways and, hence, neutralizing to some extent PKR biological effects such as apoptosis induction. Recently the role of other vFLIPs has been analysed through the genetic modification of herpesvirus saimiri (Glykofrydes et al., 2000) . Similar to the results that we report here, where MC159L is not capable of overriding PKR antiviral effects, the deletion of vFLIP from herpesvirus saimiri was not an obstacle to virus replication. These observations show that modulation of host responses to these viruses is carried out by the combined actions exerted by different proteins.
In conclusion, in this investigation we have made an in depth analysis of the relationship between MC159L and PKR. We have confirmed the importance of MC159L in regulating PKR-dependent apoptosis and the induction of the transcription factor NF-κB by this kinase. Although these actions do not correlate with alteration in the antiviral state imposed by PKR, these results suggest that some of the biological effects exerted by MC159L could be mediated through the regulation of PKR-triggered pathways. The facts that there is no physical interaction between PKR and the MC159L open reading frame product, and phosphorylation of the well characterized PKR substrate, eIF-2α, is not affected suggest that cells may contain functionally distinct pools of PKR. This is the first demonstration of the existence of PKR regulatory proteins encoded by the human poxvirus MCV.
